Despite recent acquisitions and a demerger, the GSK share price has suffered in the face of an ongoing legal battle. Still, analysts remain bullish on its long-term potential.
GSK's profit dips on FX pressures, rising OPEX - Businessday NG
GlaxoSmithKline share price rises by 2% after Q1 results
Malaysia Healthcare Market Analysis, Regulatory, Reimbursement and
GSK spinoff Haleon has no deals on immediate horizon
Insufficient Growth At GSK plc (LON:GSK) Hampers Share Price
Aluminum industry facing tough times
Economies, Free Full-Text
Pharmacy Market Size, Share, Forecast
resource.html?uri=IMMC:SWD(2020)163.ENG.xhtml.SWD_282020_29163_ENG_xhtml_02002.jpg
GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid-2022
Unhealthy competition hampers chemical firms' business recovery
FAQs - GrantsAndDonations
HowToRaiseRequest - GrantsAndDonations
Live news updates from October 13: US inflation comes in at 8.2
